Financial Analysis: Sorrento Therapeutics (OTCMKTS:SRNEQ) & Protalix BioTherapeutics (NYSE:PLX) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ:SRNE opened at $0.04 on Wednesday. The business has a fifty day simple moving average of $0.08 and a two-hundred day simple […]
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ:SRNE opened at $0.04 on Wednesday. Sorrento Therapeutics has a 52 week low of $0.16 and a 52 week […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Up 15.7 % Shares of Sorrento Therapeutics stock opened at $0.05 on Tuesday. The business’s fifty day moving average price […]
Processa Pharmaceuticals’ (NASDAQ: PCSA) shares skyrocketed by over 260% from their October lows of $0.18 per share. Shares peaked at $0.65 on November 14th and more recently has consolidated around $0.43. The reason for this surge was not immediately clear given the lack of material events. However upon digging deeper, we’ve uncovered a very interesting […]